Ongoing Phase 1 and Phase 2 clinical programs continue to exhibit long-term durable remissions in hard-to-treat cancers, including glioblastoma ...

Scientists at UCLA have discovered a potential new way to treat glioblastoma, the most aggressive type of brain cancer. Their ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...

IN8bio (NASDAQ:INAB – Get Free Report) had its target price dropped by HC Wainwright from $8.00 to $6.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” rating ...

A groundbreaking experimental treatment for glioblastoma, one of the deadliest brain cancers, has been published in Nature ...

Leavenworth’s contributions bridge laboratory research with clinical applications, paving the way for innovative cancer ...

AREAS COVERED: We discuss the use of CAR T cells in GBM, focusing on limitations and obstacles to advancement, mostly related to toxicities, hostile tumor microenvironment, limited CAR T cells ...

A new research paper was published in Oncotarget, Volume 16, on February 28, 2025, titled “Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer ...

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of ...

T cells are positioned at the frontline of the body's immune system to fight infection, cancer, and autoimmune disease. While ...

Further, T cells treated with KROS 101 showed cytotoxicity against glioblastoma cell lines and glioma cancer cells, which study authors, Admasu, et. al., concluded KROS 101 demonstrated potent ...